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817-2 Ventricular Structure and Function Using Three- 
Dimensional Echocardiography in Patients With Clinical 
Heart Failure With Preserved Ejection Fraction 
John A. Vest, Leslie Baa, Donald L. King, Lyna El Khoury Coffin, Robert R. Sciacca. 
Daniel Burkhoff, Mathew S. Maurer, Columbia University, New York, NY 
A majority of patients with heart failure (i-IF) and normal ejection fraction (EF) have 
hypertension (HTN) and lefl ventricular hypertrophy (LVH). Compared to LVH patients 
without HF, hearts of symptomatic patients are hypothesized to be smaller and have 
decreased chamber contractility. Accordingly. we compared ventricular structure and 
indexes of chamber, myocardial and arterial properties derived from 3D echocardio- 
graphic (3DE) techniques in HTN patients with and without HF. 
Methods: Left ventricular volume and mass were determined using 3DE in asymptomatic 
HTN patients (N=41) and patients wth HTN, clinical HF and normal EF (N=21). These 
measurements, combined with cuff measurement of systolic blood pressure (Pes) were 
used to derive Res (end-systolic pressure-volume ratio, an index of LV chamber contrac- 
tility), and effective arterial elastance (Ea=Pes/SV, an index of arterial afterload). 
Between group comparisons were performed with a student’s t test. To control for base- 
line differences logistic regression was employed. 
Results: The HF were older (70213 vs 59+15 years, pcO.01) with a lower mean arterial 
pressures (95+14 vs 107+10 mm Hg, pcO.01) but had a similar BMI. EF (53+4 vs 5523. 
p=O.3). LV end diastolic volumes (117*29 vs 124+33 ml, p=O.3), end-systolic volumes 
(54+14 vs 57*17 ml, p=O.5), LV mass (163+61 vs 163*40 grams, p=O.2) were not signif- 
icantly different between groups. Measures of ventricular and vascular properties, includ- 
ing Res (2.5r0.8 vs 2.6kl.O mmHg/ml, p=O.7), Ea (2.2-0.6 vs 2.leO.7 mm HglmL. 
p=O.9) and the Ea/Res ratio (0.9*0.1 vs 0.6&l, p=O.4) were also Similar between 
groups. After adjustment for baseline differences in age and blood pressure, only LV 
mass was significantly different between the cohorts (OR per IO g increase: 1.25. 95% 
Cl 1.06-I .46, p<O.Ol). 
Conclusion: Ventricular size and indexes of chamber and arterial properties and ventricu- 
lar-vascular coupling did not differ between HTN patients having normal EF with and 
without HF. These data suggests that neither decreased chamber contractility nor 
decreased chamber capacitance significantly contribute to the clinical syndrome of HF in 
the sening of a normal ejection fraction and hypertension. 
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817-3 What Differentiates Diastolic From Systolic Heart 
Failure? 
Steffen Brucks, Sanjay K. Gandhi, Wojciech Mazur, Dalane W. Krtzman, Zak K. Shihabi, 
William C. Little, Wake Forest University School of Medicine, Winston-Salem, NC 
Background: It has not been possible to independently assess the association of sys- 
tolic and diastolic abnormalities in heart failure (HF) because these functional abnormali- 
ties are used as criteria for the diagnosis. B-type natriuretic peptide (BNP) provides a 
method of confirming the presence of HF independent of left ventricular functional abnor- 
malities. 
Methods 146 patients with clinical findings of HF and an elevated BNP > 100 pg/ml 
were compared to 62 subiects without clinical HF and with a normal BNP < 100 pa/ml. Of _ 
the HF patients. 45% had an ejection fraction (EF) > 0.50 (normal EF). 36% had an EF < 
0.40 flow EFI. Svstolic function measured bv the peak svstolic mitral annular velocitv 
(cm/&) was’de&eased in both normal EF (6.2+1 .b) and iow EF (4.6*1 .I) HF patient; 
compared to patients with no HF (6.1il.l) (p < 0.0001). Diastolic function was classified 
from the left ventricular filling pattern as Grade 0 (normal), Grade 1 (impaired relaxation), 
Grade 2 (pseudonormalized), or Grade 3 (restricted filling) based on Doppler mitral inflow 
velocities and tissue Doppler mitral annular motion. All patients with HF had diastolic dys- 
function (Grade = l&0.6). HF patients with low EF had more diastolic dysfunction 
(2.1+0.6) than patients with normal EF (1.5iO.7) (p < 0.0001). The severity of HF mea- 
sured by BNP levels correlated more strongly with diastolic dysfunction (r* = 0.56) than 
systolic dysfunction (r2 = 0.32). Stroke volume was similar in patients with no HF and nor- 
mal EF HF and low EF HF. Thus, left ventricular end-diastolic volume (EDV) was greater 
in patients with low EF than high EF or no HF patients (p < 0.001). The ratio of left ven- 
tricular mass to EDV was increased in normal EF HF but not low EF HF. 
Conclusion: Low EF and normal EF HF patients have both systolic and diastolrc dys- 
function. The severity of HF correlates most closely with diastolic dysfunction. Low EF 
HF patients differ from normal EF HF patients in the type of left ventricular remodeling 
(dilatation versus hypertrophy) not in the presence of systolic or diastolic dysfunction. 
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817-4 Utility of B-Type Natriuretic Peptide in Primary Diastolic 
Dysfunction: A Quantitative Comparison With Doppler 
Echocardiographic indices 
Senthil K. Thambidorai, Richard W. Troughton, Kapil Parakh, W.H. Wilson Tang, Gary S 
Francis, Allan L. Klein, The Cleveland Clinic Foundation, Cleveland, OH 
Recent data suggest that B-type natriuretic peptide (BNP) may be helpful in diagnosing 
diastolic dysfunction (DD). We sought to examine the relationship of BNP to DD and to 
quantitate its relationship to echo indices of DD. 
Methods: We studied 101 patients with normal systolic function (EF >50%), in sinus 
rhythm (without >mild valvular disease, RV dysfunction or hypertrophic cardiomyopathy) 
referred for evaluation of LV function including trans.-mitral velocities:early (E) & late (A), 
deceleration time (DT), pulmonary vein flow-systolic (S) 8 diastolic (D), A reversal (Ar) 
and early flow propagation (VP). Based on these, DD was staged as normal, stage 1 (E/ 
A <I. DT>220msec), stage 2 (E/A l-2, DT 150-220msec) & stage 3 (E/A>2, 
DT<l50msec). BNP was taken within 24hrs of echo. 
Results: DD was present in 77% of patients. BNP was elevated in propatron to the 
severity of DD (table) and correlated significantly with E/A (r=O.43,p<O.O01), E 
(r=0.44,p<0.001), DT (r=-0.41,p<0.001), S/D (r=-0.46, p<O.OOl), left atrial area 
(r=0.4t,p<0.001), D (r=0.43, p<O.OOl), Ar (r=O.34,p=O.O15) and ENp (r=0.51.p=0.005). 
In multivariate analysis, age, E & DT were independently associated with BNP. A BNP 
value of lOOmg/dl had 66% sensitivity and 76% specificity for detecting stage 2 and 3 
DD 
DD 
Age 
BNP 
E 
A 
E/A 
DT 
D 
S/D 
VP 
Normal (n=23) Stage 1 (n=36) Stage 2 (n=34) Stage 3 (n=6) 
54.9+16 65.5*13 66.3il3 59.5 * 17 
67.6 f 82.6 1132221 364 *299 988 + 266 
62525 72+16 lOOi 99r24 
6Ozt23 91*20 66ztl6 47*34 
1.4io.4 0.79-to.13 1.6*0.6 2.5*0.6 
179*17 226+27 177+23 137*19 
51*16 40*10 61*18 62212 
1.2eO.4 1.5zto.4 0.6+0.3 0.6+0.3 
61+23 33+7 37+11 41*17 
ANOVA 
0.021 
<0.001 
<O.OOl 
<O.OOl 
<O.OOl 
<O.OOl 
0.001 
<O.OOl 
0.005 
Conclusions: In primary DD, BNP is elevated in proportion to the severity of diastolic 
abnormality and correlates significantly with traditional and newer echo indices of DD. 
BNP may be a useful tool in detecting advanced stages of DD. 
817-5 HUNC-BSBl, a Novel Gene Mainly Expressed in the 
Heart, Is Related to Left Ventricular Diastolic Function 
in Elderly Men 
Johan Arnlov, Johan Sundstrom, Lars Lind, Bertil AndrBn, Maria Andersson, Richard 
Reneland, Lars Berglund, Vladimir Kashuba, Alexei Protopopov, Eugene Zabarovsky 
Hans Lithell, Uppsala University, Uppsala, Sweden 
Background: The novel hUNC-93Bl gene has the highest expression in the head. This 
study aimed at exploring and validating the relation between genotypes of the hUNC- 
93Bl gene and indices of cardiac function and morphology in elderly men. Methods: A 
reinvestigation of the population-based ULSAM-cohort (The Uppsala Longitudinal Study 
of Adult Men) included an echocardiographic examination (ejection fraction, E/A-ratio, 
left ventricular mass index and relative wall thickness). Five single nucleotide polymor- 
phisms (SNPs) and four haplotypes of the hUNC-9381 gene were detected in a sample 
of the cohort (n=330, mean age 71 years). Analyses of the relation between these geno- 
types and the cardiac phenotype variables were performed in this sample. A validation of 
the results was performed in a different, slightly older sample of the same cohort (n=152, 
mean age 75 years). Results: In the two samples, the genotype homozygous for haplo- 
type H3 had 34% and 35% higher level of E/A-ratio compared to non-carriers (ANOVA 
p=O.O002 and 0.017, respectively) and the CIC allele of the SNP vp94 had 26% and 33% 
higher level of the E/A-ratio compared to the T/l allele (ANOVA p=O.O02 and 0.015, 
respectively) after adjustment for myocardial infarction, blood pressure, heart rate, the 
use of cardiovascular medication, diabetes and body mass Index. No other relationshlps 
between the genotypes of hUNC-9381 and indices of cardiac function and morphology 
were found. Conclusion: Associations between the SNP vp94 and haplotype H3 of the 
hUNC-9381 gene and left ventricular diastolic function (E/A-ratio) were found and vail- 
dated in a population-based cohort of elderly men. 
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1110-68 Optimization of Cardiac Resynchronization Therapy by 
Sequential Biventricular Stimulation: Results of an 
Acute Hemodynamic Study 
Klaus W. Kurzidim Thomas Neumann, Heinrich Reinke, Johannes Sperzel, Hassan 
Bahavar. Christian Reiner, Christian W. Hamm. Heinz F. Pitschner, Kerckhoff-Klinik, Bad 
Nauheim, Germany, Biotronik, Erlangen, Germany 
Background: Sequential biventricular stimulation (sBV) has been proposed to optimize 
cardiac resynchronization therapy (CRT). Our aim was to evaluate the impact of individu- 
ally optimized sBV on acute left ventricular (LV) systolic function as compared to simulta- 
neous biventricular stimulation (BV). 
Methods: 34 patients eligible for CRT underwent an invasive study with temporary multi- 
site pacing (age 64.8 f 6.3 years, 9 female, ejection fracbon 21 f 5%, QRS 174 * 23 ms, 
22 in smus rhythm). Right ventricular (RV), left ventricular (LV), and BV pacing in DDD or 
VVI mode in atrial fibrillation was performed. For sBV the optimal LV atrio-ventricular 
delay was kept constant and the RV was stimulated at intervals of +60 ms (LV leading) to 
